Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1989-01-27
1990-09-04
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
552556, A61K 3157, C07J 900, C07J 500
Patent
active
049544918
ABSTRACT:
The present invention is directed to a method for the treatment of hyperaldosteronism and related disorders which comprises administering to an appropriate patient an appropriate 18-cyanopregnane.
REFERENCES:
patent: 3092627 (1963-06-01), Wettstein et al.
patent: 3684674 (1972-08-01), Anner et al.
Viger et al., J. Steroid Biochemistry, 30, 469, 1988.
J. Steroid Biochemistry, 30, 1988, Cover & Preface.
Kalvoda et al., Helv. Chim. Acta, 49,424(1966).
Kalvoda, Helv. Chim. Acta, 51, 267 (1968).
Kalvoda et al., Helv. Chim. Acta, 52, 2106 (1969).
Kalvoda et al., Helv. Chim. Acta, 55, 356 (1972).
Freerksen et al., J. Am. Chem. Soc., 99, 1536 (1977).
Auel et al., Steroids, 31, 367 (1978).
Holbert et al., Tetrahedron Letters, 26, 1137 (1985).
Viger et al., Tetrahedron, 44, 1127 (1988).
Viger et al., J. Steroid Biochem., 30, 469 (1988).
Chemical Abstracts 74:13344t 1971) (Abstracts of German OLS 2,018,252).
Derwent Abstract 78489R (Abstract of Belgian 749,134; equivalent to U.S. Pat No. 3,684,674).
Holbert Gene W.
Johnston J. O'Neal
Carr Deborah D.
Kolano John J.
Merrell Dow Pharmaceuticals Inc.
Shah Mukund J.
LandOfFree
Method of treatment using 18-cyanoprogesterone derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treatment using 18-cyanoprogesterone derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treatment using 18-cyanoprogesterone derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-442105